• Hansa Biopharma will publish its January-September 2026 interim report on November 11, 2026.
• A results conference call follows that day at 14:00 CET / 8:00 a.m. EST, covering financial results, business developments and pipeline updates.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hansa Biopharma AB published the original content used to generate this news brief via Cision (Ref. ID: 202610280700BITN____UKPR__EN_20261027-BIT-0826-0) on October 28, 2026, and is solely responsible for the information contained therein.